Patent Assignment
Reel/Frame 018851/0559
Assignment of Assignor's Interest
Recorded: 2007-02-05
Pages: 5
Assignee
NASTECH PHARMACEUTICAL COMPANY INC.
3830 MONTE VILLA PARKWAY, BOTHELL, WASHINGTON, 98021-7266
Covered Property
(1)
COMPOSITIONS AND METHODS EMPLOYING UNIVERSAL-BINDING NUCLEOTIDES FOR TARGETING MULTIPLE GENE VARIANTS WITH A SINGLE siRNA DUPLEX
Application:
11/610,403 →
Publication:
US 2007/0254362
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Dec 29, 2009
From: MDRNA, INC.; MDRNA RESEARCH, INC.; NASTECH PHARMACEUTICAL COMPANY, INC.
To: EOS HOLDINGS LLC, AS AGENT
Reel/Frame 023708/0389 →
Change of Name
Feb 10, 2010
From: NASTECH PHARMACEUTICAL COMPANY INC.
To: MDRNA, INC.
Reel/Frame 023915/0694 →
Release of Security Interest
Feb 23, 2010
From: EOS HOLDINGS LLC, AS AGENT
To: MDRNA, INC.; MDRNA RESEARCH, INC.; NASTECH PHARMACEUTICAL COMPANY, INC.
Reel/Frame 023973/0286 →
Security Agreement (Patents)
Apr 28, 2010
From: MDRNA, INC. FKA NASTECH PHARMACEUTICAL COMPANY INC.
To: CEQUENT PHARMACEUTICALS, INC.
Reel/Frame 024300/0825 →
Release of Security Interest
Jul 30, 2010
From: CEQUENT PHARMACEUTICALS, INC.
To: MARINA BIOTECH, INC. (F/K/A MDRNA, INC.)
Reel/Frame 024767/0466 →